Archive: 21/05/2014
Dolutegravir in HIV-1 infection: Added benefit in adult patients
Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. In an early benefit ...
May 21, 2014
Researchers to study effects of early intervention on older kids
As an expert in childhood development, the University of Delaware's Mary Dozier is all too familiar with the harmful effects of early neglect on young children.
May 21, 2014